Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.16326
Abstract: This cohort study describes patterns of development, management strategies, and long-term vascular consequences of hypertension associated with ibrutinib in the non–clinical trial setting. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.5329
Abstract: Key Points Question What is the association between ondansetron exposure during pregnancy and the risk of adverse fetal outcomes? Findings In this meta-analysis of cohort studies of 456 963 pregnancies in 3 countries, treatment with ondansetron… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.54559
Abstract: Key Points Question Is the presence of an academic medical center (AMC) within a health care market associated with better outcomes for patients treated at neighboring nonteaching hospitals? Findings In this retrospective cohort study of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2022.1413
Abstract: Importance The effectiveness and safety of intravenous alteplase given before or concurrently with endovascular thrombectomy (EVT) is uncertain. Randomized clinical trials suggest there is little difference in outcomes but with only modest precision and insufficient… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51625
Abstract: To investigate biomarkers of disease progression in cerebrospinal fluid (CSF) and serum in adult patients with spinal muscular atrophy (SMA). Furthermore, we assess the clinical response to nusinersen treatment in adults with SMA over a… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2797
Abstract: PD(L)1 antibodies (anti‐PD(L)‐1) have been a major breakthrough in several types of cancer. Novel patterns of response and progression have been described with anti‐PD(L)‐1. We aimed at characterizing pseudoprogression (PSPD) among patients with various solid… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3113
Abstract: Durvalumab after concurrent chemoradiation (cCRT) is now standard of care for unresected stage III non–small cell lung cancer (NSCLC). However, there is limited data on radiation pneumonitis (RP) with this regimen. Therefore, we assessed RP… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4564
Abstract: The most frequent chemotherapeutic regimens used in children's cancer contain anthracyclines, which may have potentially cardiotoxic effects even at a later point in time. Echocardiography including tissue Doppler imaging is well‐proved noninvasive method to assess… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4779
Abstract: Immune checkpoint inhibitors (ICIs) are effective in some cancer patients; however, they may show no efficacy in others. Predictive biomarkers are crucial for appropriately selecting the patients who receive ICI therapy. This study aimed to… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30152
Abstract: The aim of the study was to analyze available data on patients treated for chronic limb‐threatening ischemia (CLTI) with the heparin‐bonded Viabahn endoprosthesis. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34734
Abstract: Patients treated with preoperative chemotherapy with stage I intermediate‐risk Wilms tumor (IR‐WT) represent the largest group of patients with Wilms tumor (WT), and they have excellent outcomes. read more here.